Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 33 (10), 725-734

Effects of L-carnitine Supplementation on Blood Pressure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Affiliations
Review

Effects of L-carnitine Supplementation on Blood Pressure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Moein Askarpour et al. J Hum Hypertens.

Abstract

L-carnitine plays a fundamental biological role in the metabolism of lipids and may positively affect blood pressure by decreasing insulin resistance, although the latter remains less clear. We aimed to assess the effects of L-carnitine supplementation on systolic (SBP) and diastolic blood pressure (DBP). A search was conducted using databases of EMBASE, PubMed, Scopus, Cochrane Library, and ISI web of Science from inception to February 2019 without limitations in language. A meta-analysis was conducted on a total of ten eligible randomized controlled trials using a random-effects model to estimate the pooled effect sizes of L-carnitine supplementation on SBP and DBP levels. Results were expressed as weighted mean difference (WMD) and 95% confidence intervals (CI). L-carnitine supplementation decreased DBP (-1.162 mmHg, 95% CI: -2.020, -0.303, p = 0.008) without changing SBP levels (-0.085 mmHg, 95% CI: -1.455, 1.285, p = 0.903). Results of the subgroup analyses revealed L-carnitine supplementation decreased DBP levels in participants with overweight and obesity (-1.232 mmHg, 95% CI: -2.297, -0.167, p = 0.023) and with doses of <2 g/d (-1.639 mmHg, 95% CI: -3.038, -0.240, p = 0.022). No evidence of publication bias was observed about the effects of L-carnitine supplementation on SBP (p = 0.307) and DBP (p = 0.729), as evidenced by the results of the Egger's test. In conclusion, L-carnitine supplementation decreased DBP without affecting SBP levels. Research is required to determine the molecular mechanism underlying the relationship between of L-carnitine on blood pressure.

Similar articles

See all similar articles

References

    1. Domest Anim Endocrinol. 2004 Jan;26(1):1-9 - PubMed

References

    1. Nutr Res. 2015 Aug;35(8):707-15 - PubMed

References

    1. Heart. 2012 Feb;98(3):254-61 - PubMed

References

    1. Am J Obstet Gynecol. 2005 Jun;192(6):2060-2 - PubMed

References

    1. Diabetes Care. 2013 Jan;36 Suppl 1:S11-66 - PubMed

References

    1. Hypertens Pregnancy. 2019 May;38(2):96-104 - PubMed

References

    1. Diabetes Res Clin Pract. 2006 Jun;72(3):231-7 - PubMed

References

    1. Nephrol Dial Transplant. 2006 Nov;21(11):3211-4 - PubMed

References

    1. PLoS Med. 2009 Jul 21;6(7):e1000100 - PubMed

References

    1. Vasc Health Risk Manag. 2014 Jun 30;10:327-32 - PubMed

References

    1. Hypertension. 2003 Nov;42(5):1050-65 - PubMed

References

    1. Biomed Res Int. 2017;2017:6274854 - PubMed

References

    1. Vasc Health Risk Manag. 2013;9:763-8 - PubMed

References

    1. Clin Exp Hypertens. 2018;40(5):476-480 - PubMed

References

    1. Cardiorenal Med. 2017 Jun;7(3):188-197 - PubMed

References

    1. Adv Clin Exp Med. 2017 Mar-Apr;26(2):333-338 - PubMed

References

    1. Nutrients. 2014 Dec 22;6(12):5992-6004 - PubMed

References

    1. Eur J Clin Nutr. 2007 Jul;61(7):892-5 - PubMed

References

    1. Endocrine. 2018 Jun;60(3):386-394 - PubMed

References

    1. Am J Kidney Dis. 2016 Feb;67(2):260-70 - PubMed

References

    1. J Am Heart Assoc. 2019 Jan 8;8(1):e009585 - PubMed

References

    1. Turk J Emerg Med. 2018 Mar 28;19(1):16-20 - PubMed

References

    1. FASEB J. 1992 Dec;6(15):3379-86 - PubMed

References

    1. Obstet Gynecol. 2004 May;103(5 Pt 1):876-80 - PubMed

References

    1. Cardiol Clin. 1998 Nov;16(4):633-44, viii - PubMed

References

    1. Life Sci. 2018 Feb 1;194:88-97 - PubMed

References

    1. J Clin Hypertens (Greenwich). 2007 Apr;9(4):249-55 - PubMed

References

    1. Regul Toxicol Pharmacol. 2006 Oct;46(1):23-8 - PubMed

References

    1. Lancet. 1990 Mar 31;335(8692):765-74 - PubMed

References

    1. Circ J. 2008 Jun;72(6):926-31 - PubMed

References

    1. Hypertension. 2009 Jul;54(1):127-33 - PubMed

References

    1. Hypertension. 2019 Apr;73(4):785-793 - PubMed

References

    1. Mol Cell Endocrinol. 1990 Dec 3;74(2):C87-9 - PubMed

References

    1. BMJ. 1997 Sep 13;315(7109):629-34 - PubMed

References

    1. JAMA. 2003 May 21;289(19):2560-72 - PubMed

References

    1. Expert Opin Drug Saf. 2014 Oct;13(10):1383-95 - PubMed

References

    1. Int J Sport Nutr Exerc Metab. 2000 Jun;10(2):199-207 - PubMed

References

    1. Prog Lipid Res. 1999 May;38(3):199-224 - PubMed

References

    1. J Endocr Soc. 2018 Mar 22;2(5):420-436 - PubMed

References

    1. Ann Nutr Metab. 2008;52(4):335-8 - PubMed

References

    1. Diabetes Metab Syndr. 2019 Jan - Feb;13(1):167-173 - PubMed

References

    1. BMJ. 2016 Feb 24;352:i717 - PubMed

References

    1. Am J Clin Nutr. 2007 Dec;86(6):1738-44 - PubMed

References

    1. Clin Exp Nephrol. 2015 Jun;19(3):331-5 - PubMed

References

    1. Heart. 2016 Dec 1;102(23):1909-1914 - PubMed

References

    1. JPEN J Parenter Enteral Nutr. 2010 May-Jun;34(3):295-9 - PubMed

References

    1. J Am Heart Assoc. 2016 Jul 12;5(7): - PubMed

References

    1. Clin Nutr ESPEN. 2016 Oct;15:1-10 - PubMed

References

    1. J Hypertens. 2015 Jun;33(6):1119-27 - PubMed

References

    1. Lipids Health Dis. 2016 Jun 17;15:107 - PubMed

References

    1. Clin Exp Hypertens. 2007 Nov;29(8):517-30 - PubMed

References

    1. Nat Med. 2013 May;19(5):576-85 - PubMed

References

    1. Curr Opin Nephrol Hypertens. 2015 Sep;24(5):417-24 - PubMed

References

    1. Ann N Y Acad Sci. 2004 Nov;1033:42-51 - PubMed

References

    1. N Engl J Med. 2013 Apr 25;368(17):1575-84 - PubMed

References

    1. BMJ. 2003 Sep 6;327(7414):557-60 - PubMed

LinkOut - more resources

Feedback